ASX/NXN (ASX/NXN)

Australian Securities Exchange: ASX/NXN · AUD

A$0.17

+0.01 (+6.3%)· Recorded snapshot

Market cap	34M
Net income (ttm)	-6.6M
EPS (ttm)	-A$0.04
Shares out	200.2M
Volume	16,616

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -6.6M
EPS (ttm): -A$0.04
Market cap: 34M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROE-236.4

P25 -108P50 -50.6P75 1.1

ROIC-580.5

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/NXN indicators

Market & fundamental data

Available fields

136

Groups with data

Currency

AUD

Showing 136 of 136 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-09-04
Enterprise value	AUD 29.6M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2021
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU0000418782
Last refreshed	2026-10-29
Market cap	AUD 34M
Price	AUD 0.17
Price currency	AUD
Sector	Healthcare
SIC code	8731
Stock price date	2026-10-29
Symbol	asx/NXN
Website	https://www.nexsen.bio

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-21.38%
FCF / EV yield	-11.31%
FCF yield	-9.82%
Industry forward P/E	28.82x
P/B ratio	6.01x
Price / tangible book value	8.59x
Sector forward P/E	34.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-86.13%
ROCE	-120.95%
ROE	-236.38%
ROIC	-580.48%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -3,321
Depreciation and amortization	AUD 1,456
EBIT	AUD -6.9M
EBITDA	AUD -6.9M
EPS	AUD -0.04
FCF per share	AUD -0.02
Financing cash flow	AUD 7.4M
Free cash flow	AUD -3.3M
Free cash flow minus SBC	AUD -4.4M
Gross profit	AUD -3.2M
Investing cash flow	AUD -3,321
Net borrowing	AUD -283
Net cash flow	AUD 4.1M
Net income	AUD -6.6M
Operating cash flow minus SBC	AUD -4.4M
Operating income	AUD -6.9M
Stock-based compensation	AUD 1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	AUD 0.03
Debt / equity	0
Interest coverage	-8.8
Long-term assets	AUD 1.7M
Long-term liabilities	AUD 12,524
Net cash (debt)	AUD 4.5M
Net cash / market cap	13.16%
Net debt / equity	-0.79
Piotroski F-Score	2
Property, plant and equipment	AUD 13,706
Shareholders' equity	AUD 5.7M
Tangible book value	AUD 4M
Tangible book value per share	AUD 0.02
Total assets	AUD 6.7M
Total cash	AUD 4.5M
Total debt	AUD 11,606
Total liabilities	AUD 1M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	AUD 5M
Current liabilities	AUD 1M
Current ratio	4.85
Net working capital	AUD -527,766
Quick ratio	4.48
Working capital	AUD 4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-84.77%
Shareholder yield	-84.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.21
1D price change	6.25%
1M price change	21.43%
1M total return	21.43%
1W price change	13.33%
1W total return	13.33%
1Y price change	-17.07%
1Y return CAGR	-17.08%
1Y total return	-17.07%
20-day SMA	AUD 0.14
200-day SMA	AUD 0.20
3M price change	-37.04%
3M total return	-37.04%
50-day SMA	AUD 0.17
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.35
52-week high date	2026-07-06
52-week low	AUD 0.11
52-week low date	2026-10-01
6M price change	-17.07%
6M total return	-17.07%
All-time high	AUD 0.35
All-time high date	2026-07-06
All-time low	AUD 0.11
All-time low date	2026-10-01
Average true range (ATR)	AUD 0.01
Average volume	245.2K
Beta (1Y)	1.44
Beta (2Y)	1.27
Change from 52-week high	-50.72%
Change from 52-week low	61.91%
Change from all-time high	-50.72%
Change from all-time low	61.9%
Change from open	3.03%
Day's gap	3.13%
Dollar volume	AUD 2,825
High price	AUD 0.17
Low price	AUD 0.17
Monthly RSI	0
Open price	AUD 0.17
Position in 52-week range	100%
Previous close	AUD 0.16
Price vs 150-day SMA	-17.64%
Price vs 20-day SMA	20.74%
Price vs 200-day SMA	-14.74%
Price vs 50-day SMA	-1.11%
Relative volume	0.07
RSI	57.9
Sharpe ratio	-0.01
Sortino ratio	0.04
Volume	16.6K
Weekly RSI	43.71
YTD price change	6.25%
YTD total return	6.25%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62.9M
Shares change (QoQ)	24.36%
Shares change (YoY)	84.77%
Shares held by insiders	48.45%
Shares held by institutions	9.27%
Shares outstanding	200.2M

Deeper analysis on ASX/NXN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/NXN report

Is a complete ASX/NXN research report available?

No complete published report is available for asx/NXN (ASX/NXN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/NXN (ASX/NXN)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/NXN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/NXN indicators

Profile and market data

Valuation

Profitability

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/NXN

Frequently asked questions